潛在免疫法 的英文怎麼說

中文拼音 [qiánzàimiǎnyìfǎ]
潛在免疫法 英文
occult immunization
  • 潛 : Ⅰ動詞1 （隱在水下） go underwater; hide under water; dive 2 （隱藏） hide3 [書面語]（涉水） wade ...
  • 免 : Ⅰ動詞1 （去掉;除掉） dismiss; relieve; remove 2 （避免） avoid; escape; avert 3 （免去） excuse s...
  • 疫 : 名詞（瘟疫） epidemic disease; pestilence
  • 法 : Ⅰ名詞1 （由國家制定或認可的行為規則的總稱） law 2 （方法; 方式） way; method; mode; means 3 （標...
  • 潛在 : latent; potential; lurking
  1. Scrape therapy is a natural treatment directed by chinese medicine theory of bowels and meridians, and widely applies the virtues of no - drug treatments like acupuncture, massage, chiropractic and cupping. through the use of edge tools, it can make the points congest by scraping the meridians, channels and points on the surface of the skin so as to improve the partial micro - circulation and dredge the channels and meridians, regulate the surplus blood, invigorate the circulation of blood, make the hearts and lungs healthy, relieve rheumatic pains and cold, eliminate the bump and relieve the pain, stimulate and improve the immunity and protection abilities of the human body, and serve the purpose of health care and curing the diseases

    刮痧療法是以中醫臟腑、經駱學說為理論指導，眾采針炙、按摩、點按、拔罐等中醫非藥物療法之所長，用利器利拭體表經脈、穴位，使受到絡絡穴位處充血，從而改善局部的微循環，起到疏通絡絡，調和盈血，活血化瘀、強健心肺、祛風散寒、消腫止痛，動員和增強肌體自身潛在的抗病能力和免疫能力，以達到扶正祛邪、保健強身治病的一種自然療法。
  2. At present, in an attempt to stimulate specific antitumor immunity, experimental models and clinical studies are currently evaluating the potent antigen - presenting capacity of dc combined with single or multiple tumor antigen epitopes. however, there are several problems in utilizing pulsing dc with synthetic immunodominant peptides from identified antigens. 1 ) the potential induction of tolerance ; 2 ) the need to determine the patient ' s hla haplotype, the limitation of therapy to patients whose tumors express defined specific tumor antigens in the context of the correct hla phenotype, the unavailability of peptides for all hla haplotypes ; 3 ) the lack of cd4 help cell - related epitopes for most antigens ; and 4 ) the ctl resulting from such protocols have a good in vitro capacity to kill peptide - pulsed target cells but only a modest capacity to kill tumor cells

    但是，學者們發現這一療法存在著如下的缺陷：單一ctl表位抗原肽的應用其抗腫瘤作用弱於多種腫瘤抗原的聯合應用，且有誘導免疫耐受的潛在危險，有時反而會促進腫瘤的生長；事先需對患者的hla單倍型進行鑒定，以確定ctl表位與hla單倍型是否匹配，目前尚缺乏能與所有hla單倍型相匹配的ctl表位，從而限制了這一療法的應用；這一療法所產生的ctl在體外能有效殺傷經腫瘤抗原肽共孵育過的靶細胞，但對腫瘤細胞的殺傷能力較弱：這種l表位抗原肽缺乏cd4汀h細胞相關的表位，因此，不能誘導有效的th細胞免疫應答。
  3. In contrast to murine studies, studies of human hscs have relied on a number of in vitro assays that identify cells with the capacity to generate hematopoietic progenitors in long - term culture and to differentiation into multiple hematopoietic lineages. recently, two elegant animal models that enable the in vivo measurement of human hscs marrow repopulating potential have been developed. one is the sheep in utero transplantation system in which human hematopoietic progenitor cells are transferred into the sheep fetus in utero before the development of the ovine immune system

    早在80年代中期， zanjani等就利用胚胎期免疫系統發育不完善，將人的造血幹細胞移植到妊娠中期胚羊腹腔內，成功地建立了人胎羊造血幹細胞嵌合體移植模型，並以此實驗模型作為體內檢測人造血幹細胞和人骨髓間充質幹細胞多向分化潛能的方法。
分享友人
分享到 Line

分享到臉書